GTM-101

About this trial

Last updated 2 years ago

Study ID

GTM-101

Status

Recruiting

Type

Observational [Patient Registry]

Placebo

Accepting

All

Not accepting

Healthy Volunteers

Trial Timing

Started 5 years ago

The objectives of this registry study are to evaluate real-world clinical outcomes and patient reported outcomes that measure the effectiveness and safety of STaRT.

Inclusion Criteria

1. Patients who undergo maximum safe resection of intracranial neoplasm(s) AND implantation of GammaTiles.

2. Willing and able to provide informed consent and to participate in all evaluations.

Exclusion Criteria

1. Inability to undergo pre-operative and post-operative imaging for disease and implant assessment.

2. Major medical or psychiatric illness, which, in the investigator's opinion would prevent completion of treatment, ability to complete assessments at the time of enrollment, and/or interfere with follow ups.

3. Lack of English language fluency sufficient to allow for completion of neurocognitive and QOL tests (which are in English).